Marsh (MRSH) is a global insurance broker that places commercial and personal coverage for clients and earns commissions and fees on it, with its Marsh McLennan Agency unit focused on middle-market firms. The structural case rests on scale and recurring fee income: the business earns steady revenue from renewals and risk advisory work that holds up through soft insurance cycles. Revenue growth of 8.1% and a 27.2% return on equity sit alongside an 18.4% operating margin, which is solid for a broker with a 44.1% gross margin. At a trailing P/E of 22.5 against a forward P/E of 15.0, the market is pricing in meaningful earnings growth, so the question for the PM is whether that expansion is credible. Worth a deeper look if you want exposure to insurance pricing and brokerage fee durability, but the 60/100 score and absence from major indices suggest the case needs more work before it earns a position.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 18 Oct 2026, 10:18 CEST | Rating | Overvalued | first publication | $188 |
| 18 Oct 2026, 01:52 CEST | ACCE price target | $207 | $205 | $188 |
| 18 Oct 2026, 00:00 CEST | Fair value | $122 | $175 | $188 |
| 17 Oct 2026, 00:00 CEST | Fair value | $175 | $170 | $187 |
| 14 Oct 2026, 00:00 CEST | Fair value | $170 | $174 | $177 |
| 10 Oct 2026, 00:00 CEST | Fair value | $174 | $106 | $177 |
| 30 Sept 2026, 00:00 CEST | Fair value | $106 | $109 | $169 |
| 19 Sept 2026, 00:00 CEST | ACCE price target | $205 | first publication | $175 |
| 18 Sept 2026, 00:00 CEST | Fair value | $109 | $112 | $177 |
| 13 Sept 2026, 00:00 CEST | Fair value | $112 | $111 | $177 |
Answered from Marsh Common Stock fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| MRSH Marsh Common Stock | $197.48 | $121 | 63% above | 22.8x | 27.2% | 80 | 70 |
| AJG Arthur J. Gallagher & Co. Common Stock | $270.98 | $116 | 134% above | 44.9x | 6.7% | 67 | 62 |
| AON Aon plc Class A Ordinary Shares (Ireland) | $306.80 | $202 | 52% above | 16.2x | 44.7% | 78 | 52 |
| WTW Willis Towers Watson Public Limited Company Ordinary Shares | $332.18 | $210 | 58% above | 20.6x | 19.8% | 75 | 62 |
| BRO Brown & Brown Inc. Common Stock | $74.49 | $60 | 24% above | 23.5x | 10.0% | 74 | 71 |
| ERIE Erie Indemnity Company Class A Common Stock | $256.80 | $143 | 80% above | 23.0x | 24.8% | 70 | 48 |
| RYAN Ryan Specialty Holdings Inc. Class A Common Stock | $44.49 | $23 | 91% above | 61.5x | 22.1% | 64 | 52 |
Where MRSH ranks against its sector peers on each metric.